In re Brana: Patent Utility Does Not Require FDA-Level Proof
The Federal Circuit held that in vitro and mouse-model data establish patent utility for a cancer drug candidate, well before FDA-grade human evidence exists.
A utility patent protects how an invention works. It is the patent most people mean when they say “patent,” and it makes up roughly nine out of every ten patents the USPTO grants. If your invention does something, performs a process, or is built a particular way to achieve a result, utility is the category you are in.
The statutory boundary is 35 U.S.C. § 101, which allows a patent on any new and useful process, machine, article of manufacture, or composition of matter, or any new and useful improvement of one. Those four categories are broader than they sound. A process can be a manufacturing method or a way of treating a disease. A composition of matter can be an alloy, a pharmaceutical, or a gene-editing reagent. An improvement on something that already exists counts, which is why most patents are refinements rather than breakthroughs.
The protection attaches to the claims, not to the product you ship or the description you wrote. Claims are numbered sentences at the end of the patent that define the invention’s boundary in words, the way a deed defines a parcel by its edges. Everything else in the document, including drawings and the written description, exists to support and explain those claims.
This has a consequence people routinely misunderstand: two products can look nothing alike and still infringe the same patent, and two products can look identical while only one infringes. What matters is whether the accused thing contains every element of at least one claim.
Four requirements do most of the work, and an application fails if it misses any:
A utility patent runs 20 years from the earliest non-provisional filing date. That clock starts at filing, not at grant, so the two-to-three years of examination come out of your term rather than being added to it. Real enforceable life is typically 17 to 18 years.
It is not free to keep. Maintenance fees fall due at 3.5, 7.5, and 11.5 years after issuance, escalating each time, and the patent lapses if you miss one. Roughly half of all utility patents are abandoned before term for exactly this reason: the owner decides the invention is no longer worth the upkeep.
Utility patents cover the functional core of most technology you use:
Note what each one claims: a function, a process, or a composition. None claims an appearance. That is the line between utility and design.
A utility patent requires you to publish the invention in full. Applications are laid open 18 months after the priority date whether or not the patent ever issues, so a failed application can hand your method to competitors for nothing.
If your advantage is a process nobody can see in the finished product, and you can genuinely keep it quiet, a trade secret may protect it longer. Coca-Cola’s formula would have entered the public domain generations ago as a patent. The trade-off is real and runs in both directions: a trade secret dies the moment someone reverse-engineers or independently discovers it, and neither is infringement.
What is a utility patent? A utility patent protects the functional aspects of an invention: how it works, how it is used, and how it is made. It covers processes, machines, articles of manufacture, and compositions of matter under 35 U.S.C. § 101. It is the most common patent type, accounting for roughly 90 percent of patents the USPTO issues.
How long does a utility patent last? Twenty years from the earliest non-provisional filing date, not from the grant date. Because examination commonly takes two to three years, the enforceable life after issuance is usually closer to 17 or 18 years. Maintenance fees are due at 3.5, 7.5, and 11.5 years, and the patent expires early if you miss one.
What is the difference between a utility patent and a design patent? A utility patent protects how something works. A design patent protects how something looks, meaning its ornamental appearance. A phone’s battery management method is utility subject matter; the phone’s distinctive rounded shape is design subject matter. Many products carry both, and the two are examined under different standards.
What are examples of utility patents? The telephone (Bell, No. 174,465), the Wright brothers’ flying machine (No. 821,393), the transistor, the PCR process for amplifying DNA, one-click ordering, and the lithium-ion battery chemistries in most consumer electronics. Each claims a function or method rather than an appearance.
Going further: How to Patent an Idea, step by step .
This page is general legal information, not legal advice, and it does not create an attorney-client relationship.
The Federal Circuit held that in vitro and mouse-model data establish patent utility for a cancer drug candidate, well before FDA-grade human evidence exists.
In 1817 Justice Story held that useful means only not frivolous or immoral, setting the low utility bar that still governs patent law today.
The Federal Circuit affirmed the rejection of a cold-fusion patent application, holding that once the Patent Office shows skilled artisans would reasonably doubt an invention's utility, the burden shifts to the applicant to prove it works.
Judge Alsup wiped out a $32.5 million verdict by holding that Sonos's zone-scene patents were equitably unenforceable for prosecution laches. Then the Federal Circuit reversed on prejudice. A roadmap to the limits of the continuation game.
The Federal Circuit refused patents on five expressed sequence tags whose only disclosed uses were generic research applications, sharpening the 'specific and substantial' utility standard for the genomics era.
The Federal Circuit held that an invention designed to fool consumers does not fail the utility requirement, retiring the long-dormant doctrine that deceptive or immoral inventions are unpatentable.
The Supreme Court held that a novel process for making a chemical with no known use fails the utility requirement, planting the doctrinal seed of 'substantial' utility that still governs the chemical and biotech arts.